Meihua Han

1.6k total citations
83 papers, 1.3k citations indexed

About

Meihua Han is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Meihua Han has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 34 papers in Biomaterials and 19 papers in Biomedical Engineering. Recurrent topics in Meihua Han's work include Nanoparticle-Based Drug Delivery (33 papers), RNA Interference and Gene Delivery (18 papers) and Dendrimers and Hyperbranched Polymers (17 papers). Meihua Han is often cited by papers focused on Nanoparticle-Based Drug Delivery (33 papers), RNA Interference and Gene Delivery (18 papers) and Dendrimers and Hyperbranched Polymers (17 papers). Meihua Han collaborates with scholars based in China, Denmark and United Kingdom. Meihua Han's co-authors include Xiangtao Wang, Yifei Guo, Haowen Li, Hui Ao, Yanna Zhao, Zhengqi Dong, Mingshi Yang, Yanhong Wang, Dongmei Cun and Tingting Liu and has published in prestigious journals such as Scientific Reports, Carbohydrate Polymers and Molecules.

In The Last Decade

Meihua Han

81 papers receiving 1.3k citations

Peers

Countries citing papers authored by Meihua Han

Since Specialization

Citations

This map shows the geographic impact of Meihua Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meihua Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meihua Han more than expected).

Fields of papers citing papers by Meihua Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meihua Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meihua Han. The network helps show where Meihua Han may publish in the future.

Co-authorship network of co-authors of Meihua Han

This figure shows the co-authorship network connecting the top 25 collaborators of Meihua Han. A scholar is included among the top collaborators of Meihua Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meihua Han. Meihua Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intratumoral injection of two dosage forms of paclitaxel nanoparticles combined with photothermal therapy for breast cancer 2024 ·Chinese Herbal Medicines ·Lina Sun, (unknown), (unknown), Xinxin Liu, Yifei Guo, Xiangtao Wang, Meihua Han	2
2	Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment 2024 ·International Journal of Nanomedicine ·(unknown), Xiangtao Wang, Meihua Han, Yifei Guo	19
3	Simple preparation and greatly improved oral bioavailability: The supersaturated drug delivery system of quercetin based on PVP K30 2024 ·Drug Delivery and Translational Research ·(unknown), Haowen Li, (unknown), (unknown), Hui Ao, Meihua Han, Yifei Guo, Hongda Zhang, Zhenzhong Wang, Xiangtao Wang	4
4	Combination of chemotherapy with low-dose doxorubicin/Lycium barbarum polysaccharide and photothermal therapy with polypyrrole nanoparticles for treating breast cancer 2023 ·Journal of Drug Delivery Science and Technology ·Lina Sun, (unknown), (unknown), Xinxin Liu, Yu Xia, Xiangtao Wang, Yifei Guo, Meihua Han	10
5	Mitochondrial-Targeted Triphenylphosphonium–Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation 2023 ·Pharmaceutics ·(unknown), (unknown), Xiaorui Liu, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang	6
6	A γ-Glutamyl Transpeptidase (GGT)-Triggered Charge Reversal Drug-Delivery System for Cervical Cancer Treatment: In Vitro and In Vivo Investigation 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Meihua Han, Yifei Guo, Xiangtao Wang	16
7	Hydrophilic Poly(glutamic acid)-Based Nanodrug Delivery System: Structural Influence and Antitumor Efficacy 2022 ·Polymers ·Yifei Guo, (unknown), Bo Yu, (unknown), (unknown), Xiaotong Wang, (unknown), Meihua Han, Zhengqi Dong, Xiangtao Wang	14
8	In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug 2021 ·Asian Journal of Pharmaceutical Sciences ·(unknown), (unknown), Tingting Liu, Meihua Han, Dongmei Cun, Jelena Đuriš, Mingshi Yang, Sandra Cvijić	18
9	Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activity in vitro and in vivo 2021 ·Nanotechnology ·Yuan Zou, Xiangtao Wang, (unknown), (unknown), Jianwei Han, Yifei Guo, (unknown), Meihua Han	14
10	Nanoadsorbents preparing from oligoethylene glycol dendron and citric acid: Enhanced adsorption effect for the removal of heavy metal ions 2020 ·Colloids and Surfaces B Biointerfaces ·Xuejie Zhang, Xiangtao Wang, (unknown), (unknown), Meihua Han, Yifei Guo	11
11	A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy 2019 ·International Journal of Pharmaceutics ·(unknown), (unknown), Haowen Li, Yifei Guo, Xiangtao Wang, Meihua Han	19
12	Polydopamine-based surface modification of paclitaxel nanoparticles for osteosarcoma targeted therapy 2019 ·Nanotechnology ·(unknown), (unknown), Xiaoyu Qi, Yifei Guo, Yue Feng, Xiangtao Wang, Meihua Han	29
13	Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice 2018 ·RSC Advances ·Meihua Han, Xiaoyu Qi, (unknown), Yijing Li, Yifei Guo, Xiangtao Wang, Feng Li	3
14	Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy 2018 ·Drug Delivery ·(unknown), (unknown), (unknown), Haowen Li, Yifei Guo, Xiangtao Wang, Meihua Han	64
15	Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice 2018 ·Drug Delivery ·Haowen Li, Yijing Li, Hui Ao, (unknown), Meihua Han, Yifei Guo, Xiangtao Wang	42
16	Combined administration on You-Gui Yin and low-dose Raloxifene partially attenuates the bone loss in ovariectomized mice through the proliferation and osteogenic differentiation of bone marrow stromal cells 2018 ·Phytomedicine ·Xiaoyu Qi, Hao Liu, (unknown), Xiangtao Wang, (unknown), Yifei Guo, Ting Hao, Baoxin Zhang, (unknown), (unknown), Meihua Han	10
17	Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules 2018 ·European Journal of Pharmaceutical Sciences ·Yifei Guo, Ting Wang, Shuang Zhao, (unknown), Meihua Han, Zhengqi Dong, Xiangtao Wang	4
18	Well-defined podophyllotoxin polyprodrug brushes: preparation via RAFT polymerization and evaluation as drug carriers 2016 ·Polymer Chemistry ·Yifei Guo, (unknown), (unknown), (unknown), Yanna Zhao, Meihua Han, Min‐Can Wang, Xiangtao Wang	14
19	A codendrimer of PAMAM decorated with oligoethylene glycol dendrons: synthesis, self-assembly, and application as a drug carrier 2013 ·Soft Matter ·Yifei Guo, Yanna Zhao, Meihua Han, Jing Zhao, (unknown), (unknown), Xiangtao Wang, (unknown), (unknown)	7
20	Development of a UPLC-ESI-MS/MS Assay for 20(S)-Protopanaxadiol and Pharmacokinetic Application of Its Two Formulations in Rats 2010 ·Analytical Sciences ·Meihua Han, Jing Chen, Shilin Chen, Xiangtao Wang	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact